Varaico: Literature-Extracted Genetic Variants

Gene:LZTR1
Variant:p.R340*
Back to variants list

LZTR1

NM_006767.4:p.R340*

Associated Papers

Frequency enrichment of coding variants in a French-Canadian founder population and its implication for inflammatory bowel diseases.

Bhérer C et al.

Medrxiv : the Preprint Server for Health Sciences, 2025

40791678 (PubMed )
Supplement: media-2.xlsx › Table_S12_ClinVar_PLP_variants

Effects of higher-than-expected control population allele frequency on classification of loss-of-function variants in cancer susceptibility genes.

Smith MJ et al.

Journal of Medical Genetics, 2025

Further delineation of the SCAF4-associated neurodevelopmental disorder.

Schmid CM et al.

European Journal of Human Genetics : Ejhg, 2025

39668183 (PubMed )
Supplement: 41431_2024_1760_MOESM2_ESM.xlsx › Tabelle1

Multi-locus inherited neoplasia alleles syndromes in cancer: implications for clinical practice.

Yuen J et al.

European Journal of Human Genetics : Ejhg, 2025

39843919 (PubMed )
Supplement: 41431_2025_1785_MOESM2_ESM.pdf

Heterozygosity for loss-of-function variants in LZTR1 is associated with isolated multiple café-au-lait macules.

Mastromoro G et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2024

Familial schwannomatosis carrying LZTR1 variant p.R340X with brain tumor: A case report.

Ibe M et al.

Molecular Genetics and Metabolism Reports, 2024

Phenotypic Expansion of Autosomal Dominant LZTR1-Related Disorders with Special Emphasis on Adult-Onset Features.

Uliana V et al.

Genes, 2024

The landscape of rare genetic variants in familial Waldenström macroglobulinemia.

Pemov A et al.

Blood Neoplasia, 2024

39036705 (PubMed )
Supplement: BNEO_NEO-2023-000111-mmc4.xlsx › Supplementary_Table_4

Burden of Mendelian disorders in a large Middle Eastern biobank.

Aamer W et al.

Genome Medicine, 2024

38584274 (PubMed )
Supplement: 13073_2024_1307_MOESM1_ESM.xlsx › Table_S3

LZTR1 loss-of-function variants associated with café au lait macules with or without freckling.

Horn S et al.

Frontiers in Neurology, 2024

Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors.

Vodicska B et al.

World Journal of Pediatrics : Wjp, 2023

36914906 (PubMed )
Supplement: 12519_2023_700_MOESM1_ESM.xlsx › Driver_list

Comparison of the frequency of loss-of-function LZTR1 variants between schwannomatosis patients and the general population.

Deng F et al.

Human Mutation, 2022

35391499 (PubMed )
Supplement: HUMU-43-919-s002.xlsx › Sheet1

Genomic analyses of 10,376 individuals in the Westlake BioBank for Chinese (WBBC) pilot project.

Cong PK et al.

Nature Communications, 2022

35618720 (PubMed )
Supplement: 41467_2022_30526_MOESM5_ESM.xlsx › Data_2

Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer.

Wen H et al.

Bmc Cancer, 2022

35578198 (PubMed )
Supplement: 12885_2022_9602_MOESM9_ESM.xlsx › Table_S6

Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification.

Liu T et al.

Nature Communications, 2022

35347147 (PubMed )
Supplement: 41467_2022_29336_MOESM8_ESM.xlsx › Sheet1

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models.

Lim SM et al.

Therapeutic Advances in Medical Oncology, 2022

Family history assessment significantly enhances delivery of precision medicine in the genomics era.

Bylstra Y et al.

Genome Medicine, 2021

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer.

Zhao ZM et al.

Bmc Cancer, 2019

30665374 (PubMed )
Supplement: 12885_2019_5290_MOESM1_ESM.xlsx › CCNE1ms_forSupplData_FMOne_Pilo

Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.

Umeki I et al.

Human Genetics, 2019

Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.

Kehrer-Sawatzki H et al.

Human Genetics, 2018

The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.

Kehrer-Sawatzki H et al.

Human Genetics, 2017

27921248 (PubMed )
Supplement: 439_2016_1753_MOESM1_ESM.doc

Expanding the mutational spectrum of LZTR1 in schwannomatosis.

Paganini I et al.

European Journal of Human Genetics : Ejhg, 2015

Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.

Yamamoto GL et al.

Journal of Medical Genetics, 2015

Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival.

Rodriguez Almaraz E et al.

Neuro-oncology Advances, 0

40051658 (PubMed )
Supplement: vdaf024_suppl_supplementary_tables_s1-s4.xlsx › Table_S2
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."